PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer

NCT03638297 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: PD-1 antibody + cox inhibitor

Sponsor

Sun Yat-sen University